Patient-reported outcomes (PROs) capture patients’ direct perspectives on their health, symptoms, and quality of life—offering critical insights into how therapies impact the people they’re designed to help. Register here to join us: ow.ly/94go50WXOeb #WeSpeakScience

Starting Oct 1, 2025, all De Novo submissions to FDA must use eSTAR (electronic Submission Template And Resource). #WeSpeakScience

Join Pfizer's Angela Russell Winnier, Moderna's Tatyana Wanderer, and me for a dynamic session designed to elevate medical writers impact and influence. 2025 AMWA Medical Writing & Communication Conference 📅Thurs Nov 6 ⏰ 1:45 - 2:45 PM #MedicalWriting #WeSpeakScience

Which FDA special program is the right 'flavor' for your next submission? Stop by Poster #18 at the #AMWA2025 #MedicalWriting & Communication Conference to discuss FDA's special programs for drug approval with WI's Maureen Piotrowski and Jessica Rickert. #WeSpeakScience #FDA

Join WI's Beth Knight for a roundtable discussion to explore effective strategies for navigating complex conversations and relationships with clients and colleagues. 📅Friday November 7 ⏰7:30 AM - 8:45 AM #MedicalWriting #WeSpeakScience #AMWA2025

Join WI’s Elise Eller for a roundtable discussion on volunteering with #AMWA, a rewarding way to grow your career and contribute to your medical writing community #WeSpeakScience @ammedwriters

Join WI’s Laura Bisogno and Keeley Spiess at Poster #17 at the #AMWA2025 Medical Writing & Communication Conference to discuss essential strategies for intentional communication, effective screen-sharing, and maximizing attendee engagement. #MedicalWriting #WeSpeakScience #WFH

Join us for a noncommercial webinar on combination products. Combination products—integrating two or more therapeutic or diagnostic components — are driving innovation across the pharmaceutical industry. Register: ow.ly/LNyx50Xmfvu #WeSpeakScience #webinar

I wanted to share some images from the recent @AMmedWriter 's conference. Wishing all of our colleagues, clients, and the communities and patients we serve a happy Thanksgiving. We’re grateful for you and excited for what’s ahead.

Today we are celebrating with one of our favorite traditions: Cookie Watch - the time of year when WI cookies are sent to every employee. The big question becomes: who will be the first to get their cookies? Wishing everyone a sweet #nationalcookieday!

Interested in learning about clinical trials and the documentation that supports them? Please join WI’s Claire Gianakas's, PhD, virtual informational session on #MedicalWriting. Date: 12/17 (1:00–2:00pm ET). Register: [email protected]. #WeSpeakScience

WI’s Maureen Piotrowski, MBA discusses roles in #ClinicalDevelopment and #RegulatoryWriting with UMass Amherst on 12/18 (12:30 – 1:30pm ET). Registration is open to UMass Amherst students only. #MedicalWriting #WeSpeakScience UMass Amherst UMass Amherst Graduate School

UT Southwestern, ever wondered if a career in #ClinicalDevelopment or #RegulatoryWriting is for you? Join WI’s Claire Gianakas, PhD, on 12/18 from 12:00-1:00pm CT to hear more. Registration is open to UT Southwestern students. #MedicalWriting #WeSpeakScience

Wondering about science, medicine, and U.S. FDA approval? Duke University please join WI’s Sam Stadmiller, PhD, for a virtual session on #MedicalWriting. Date/time: 1/22, 11:00-12:00pm ET #WeSpeakScience

At WI, we’re eager to share our love of #MedicalWriting. WI’s Hannah Dewald, PhD, is hosting: Medical Writing Info Session Location: virtual Date/time: 2/5 5:00-6:00pm ET to register, please mail: [email protected] #WeSpeakScience #MedicalWriting

Purdue University are you interested in the intersection of science, medicine, and regulatory approval? Haroon’s session is for you! Date: February, 19 1:30-2:30pm CT. Registration is open to Purdue students only. #WeSpeakScience #RegulatoryWriting

CDRH authorized 124 novel medical devices in 2025 and announced a pilot program for digital health devices. Enjoy some other highlights in this infographic and read the report for more details! ow.ly/9vQ550YbK0J #WeSpeakScience #regulatorywriting

There’s something special about bringing a fully remote team together. Last month, WI gathered for our annual in-person corporate training. I'm grateful for our team and our time together to learn, serve, and connect. #WeSpeakScience #MedicalWriting

As of Feb 2, 2026, the FDA’s eSTAR Program has officially entered the QMSR era! For medical device manufacturers, this is a milestone in global harmonization. Download the eSTAR templates at: ow.ly/ELmv50YiUYC #WeSpeakScience #MedicalDevices #RegulatoryPublishing #eSTAR

Tomorrow is Rare Disease Day WI is honored to support the rare disease community, who deserve equity in care and diagnosis. We must continue advocating for the research and innovation needed to close the 95% treatment gap. #MedicalWriting #WeSpeakScience #RareDiseaseDay